SASalvius Bakari Amuri

Salvius Bakari Amuri

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Salvius Bakari Amuri has a total of 65 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Ecosystem Functions and Services in the Congo Basin

    by Salvius Amuri Bakari, Valentin Chribagula Bashige, Cedrick Shakalenga Mutombo, John Byanga Kahumba

    The Congo Basin, the second-largest tropical forest in the world, is vital to global ecological balance. This chapter explores its ecosystem functions and services, highlighting the immensity of its contribution through: ( i ) global climate regulation services by storing large amounts of carbon from plants. The region also plays a significant role in regulating water cycles; ( ii ) provisioning services by supplying numerous direct resources: wood, nontimber forest products and food for the region’s populations; ( iii ) supporting services, including soil formation, pollination and nutrient cycling, which are fundamental to other services and are maintained due to the exceptional biodiversity of the Congo Basin, which is the driving force behind them; ( iv ) cultural services for humanity in general, based on the immense spiritual, recreational and aesthetic value of the region’s rich biodiversity, which offers opportunities for tourism and scientific research. However, the Congo Basin faces enormous challenges related to human activities and economic pressures, which threaten its ability to provide vital services. Analysis of available data highlights the inadequacy and sometimes total absence of scientific data that could guide local and regional policies on sustainable development in the Congo Basin. Urgent and substantial investment in research is essential for the optimal use of the region’s natural resources.

  • Open Access

    Aristolochia Plant Used in Congolese Traditional Medicine: Ethnopharmacology and Chromatographic Analysis for Aristolochic Acids Identification and Quantification

    by Papy M. Moke, Salvius A. Bakari, Julie Carette, Vianney N. Ntabaza, Cedrick S. Mutombo, Pierre Duez, Amandine Nachtergael, Joh B. Kahumba

    The Aristolochia genus contains aristolochic acids (AAs), nephrotoxic and carcinogenic compounds found in many species. Although the use of Aristolochia has been restricted worldwide due to safety concerns, no information is currently available on the species occurring in the flora of the Democratic Republic of the Congo (DRC). This lack of information regarding occurrence, use, and chemical composition of Aristolochia species limits the evaluation of potential exposure risks associated with traditional medicinal practices. This study identified Aristolochia species reported in the DRC through a bibliographic survey and assessed the presence of AAs in A. heppii, a species native to Katanga. Microscopic examination of root powders and HPLC-DAD/MS analysis of hydroalcoholic and aqueous extracts were performed according to the European Pharmacopoeia on one authenticated sample and twelve commercial samples purchased in Lubumbashi. Microscopy confirmed diagnostic features consistent with Aristolochia. Mass spectrometry analysis identified AAs, with AA-I quantified in hydroalcoholic extracts at 566 ± 5 ppm to 3533 ± 32 ppm (0.057–0.353% w/w) and in the aqueous extract at 204.2 ± 0.4 ppm (0.020% w/w). These results demonstrate that traditional preparations of A. heppii may lead to exposure to AA-I and underline the need for risk assessment and regulatory oversight.


  • Open Access

    Validated HPLC–DAD Method for Acacetin Quantification in Calea urticifolia (Mill.) DC. Leaves coupled with Microscopic, HPTLC and Low-Field NMR Authentication for Quality Control of Commercial Samples

    by Papy M. Moke, Elodie B. Nsasi, Salvius Bakari Amuri, Julie Carette, Yves Gossuin, Benjamin Z. Gbolo, Vianney N. Ntabaza, Cedrick Mutombo Shakalenga, Pierre Duez, Amandine Nachtergael, et al.

    The physicochemical characterization of Calea urticifolia leaves total polar extracts by HPTLC and NMR, coupled with microscopy and a newly developed and validated HPLC-DAD method for the determination of acacetin, allowed to verify the authenticity and quality of samples sold in Lubumbashi, DR. Congo. The HPTLC profiles were determined on an F254 silica plate with ethyl acetate-water-formic acid-glacial acetic acid (100:26:10:10, v/v/v/v) as the mobile phase and an aminoethyl ester diphenylboric acid - PEG400 reagent for spot visualization. The LF-NMR spectra were recorded at 80 MHz (32 scans; acquisition time, 3.2 s; repetition time, 10 s). The HPLC analysis of acacetin was performed on a C18 reverse phase column (100x4.6 mm) with a gradient acetonitrile-water, each acidified with 0.05 % formic acid (flow rate, 1 mL/min; column t°, 30°C; detection by DAD and ESI-MS in positive ion mode). The HPLC method was validated according to ICH Q2(R2) (2022) guidelines, evaluating selectivity, linearity, sensitivity (limits of detection and quantification, 2.45 and 7.71 µg/mL, respectively), and precision (CV% total, 6.08 %). In 12 authentic samples collected in the wild at different sites and seasons, the acacetin content ranged from 0.03 to 0.09 % (w/dw), whereas in eight commercial samples from Lubumbashi markets, it ranged from 0.01 to 0.07 % (w/dw). From these commercial samples, physicochemical analyses (microscopy, HPTLC, LF-NMR and HPLC-DAD) detected two noncompliant samples with significant low contents in acacetin (< 0.03 %, w/dw) and one atypical sample (HPTLC, LF-NMR).

  • Open Access

    Ethnomedical Knowledge of Plants Used in Traditional Medicine in Mampa Village, Haut‐Katanga Province, Democratic Republic of the Congo

    by Bashige Chiribagula Valentin, Biayi Benaja Martin, Bakari Amuri Salvius, Lumbu Simbi Jean Baptiste

    The inhabitants of the village of Mampa have developed a rich corpus of knowledge and practices for treating pathologies using plants that are worthy of preservation, perpetuation, and promotion. They draw on the region’s rich biodiversity, particularly in the Miombo clear forest. However, to date, no documentation of their ethnomedicinal knowledge exists. This descriptive cross‐sectional study was conducted between November 2022 and October 2023. It employed a direct, face‐to‐face interview with the Mampa village population and a guide questionnaire. A total of 400 respondents were included in the study (sex ratio M/F = 0.9; mean age: 48.0 ± 4.0 years; experience: 14.5 ± 2.0 years), and the majority (93.8%) reported that they learned about plants from their families. These individuals mainly use plants as a first‐line treatment (100%) and provided information on 38 plants. The most commonly cited species were Anisophyllea pomifera and Brachystegia boehmii with 46 citations, while the most commonly used plant was Landolphia kirkii with six recorded uses. This is the first report of Entandrophragma delevoyi and Pterocarpus brenanii as medicinal plants. Most of these plants are trees, comprising 29 from 23 genera belonging to 24 families, with a notable prevalence of Fabaceae (10 plants). Thirty‐two diseases are indicated for treatment, with a predominance of gastrointestinal disorders (8 recipes, 7 plants, 152 citations). The root is the most used organ, with 21 recipes and 14 plants, while decoction is the most common preparation method, with 41 recipes and 19 plants. This study’s findings indicate that a significant number of medicinal plants are used in traditional Mampa medicine to treat various diseases. Some of these species are endemic to the Miombo biodiversity, while others are shared with other cultures and regions. A series of pharmacological studies are currently underway to validate some of the reported plant indications.


  • Open Access

    Ethnomedical knowledge of plants used in alternative medicine to treat hemorrhoidal diseases in Lubumbashi, Haut-Katanga province, Southern Democratic Republic of Congo

    by Bashige Chiribagula Valentin, Okusa Ndjolo Philippe, Muhona Melman, Manya Mboni Henry, Bakari Amuri Salvius, Lumbu Simbi Jean Baptiste

    A variety of medicinal plants are used in traditional medicine in Lubumbashi for the management of hemorrhoidal diseases. However, no investigation has been conducted to gather the knowledge required for this type of management in the region. The present study was conducted to inventory the plants used in Lubumbashi to treat hemorrhoidal diseases and to relate their ethnomedical characteristics. This study was conducted between March 2022 and February 2023 by interviews using semi-structured questionnaire with households (n = 1520), herbalists (n = 25), and traditional healers: THs (n = 59). The 1,604 respondents (sex ratio M/F = 0.9; mean age: 56 ± 3 years; experience: 12 ± 3 years) provided information on 100 taxa, 84 of which are used against internal hemorrhoids, Phyllanthus amarus being the most cited (Citation Index, CI: 0.76). Most of them are trees (38%) or shrubs (32%), belonging to 90 genera and 45 families dominated by the Fabaceae (10%) and Asteraceae (9%). They are indicated in 76 other pathologies, dominated by gastrointestinal disorders (GID), wounds and sexually transmitted infections (CI > 0.57). From these 100 taxa, 117 anti-hemorrhoidal formulations were derived, 11 of which combined more than one plant. In all these recipes, the leaf is the most commonly used part (> 60%) and the liniment (> 45%) is the most popular form of application. For the first time, this study reports 14 taxa as plants used in the treatment of hemorrhoids. Among these taxa, Ficus stuhlmannii, Ficus laurifolia, and Ocimum centraliafricanum are listed as medicinal plants for the first time. Khaya nyasica, and Syzygium cordatum, each with 11 uses, have the highest traditional medicinal value. The findings of this study indicate that a significant number of medicinal plants are used in traditional medicine in Lubumbashi for the treatment of hemorrhoidal diseases. Some of these plants are endemic to the biodiversity area, while others are shared with other cultures and regions. A series of pharmacological studies is currently underway with the objective of validating the anti-hemorrhoidal properties of these plants and in order to identify phytochemical compounds responsible of this activity.


  • Open Access

    Ethnomedical knowledge of plants used in traditional medicine in Mampa village, Haut-Katanga province, Democratic Republic of Congo

    by Bashige Valentin Chiribagula, Bakari Amuri Salvius, Biayi Benaja Martin, Lumbu Simbi Jean Baptiste

    Background The inhabitants of the village of Mampa have developed a rich corpus of knowledge and practices for treating pathologies using plants that are worthy of preservation, perpetuation, and promotion. They draw on the region's rich biodiversity, particularly in the Miombo clear forest. However, to date, no documentation of their ethnomedicinal knowledge exists. Methods This descriptive cross-sectional study was conducted between November 2022 and October 2023. It employed a direct, face-to-face interview with the Mampa village population and a guide questionnaire. Results A total of 400 respondents were included in the study (sex ratio M/F = 0.9; mean age: 48.0 ± 4.0 years; experience: 14.5 ± 2.0 years), and the majority (93.8%) reported that they learned about plants from their families. These individuals mainly use plants as a first-line treatment (100%) and provided information on 38 taxa. The most commonly cited species were Anisophyllea pomifera and Brachystesia boehmii with 46 citations, while the most commonly used taxon was Landolphia kirkii with six recorded uses. This is the first report of Entandrophragma delevoyi and Pterocarpus brenanii as medicinal plants. Most of these taxa are trees, comprising 29 from 23 genera belonging to 24 families, with a notable prevalence of Fabaceae (10 taxa). 81 pathologies are indicated for treatment, with a predominance of gastrointestinal disorders (8 recipes, 7 taxa, 152 citations). The root is the most used organ, with 21 recipes and 14 taxa, while decoction is the most common preparation method, with 41 recipes and 19 taxa. Conclusions This study's findings indicate that a significant number of medicinal plants are used in traditional Mampa medicine to treat various diseases. Some of these species are endemic to the biodiversity area, while others are shared with other cultures and regions. A series of pharmacological studies are currently underway to validate some of the reported plant indications.


  • Open Access

    A Triangulation of Information from Healthcare Workers and Patients about the Concurrent Use of Traditional Medicine and Conventional Prescribed Medicines for Schistosomiasis in iLembe District, KwaZulu-Natal, South Africa

    by Aganze Gloire-Aime Mushebenge, Samuel Chima Ugbaja, Nonkululeko Avril Mbatha, Manimani Ghislain Riziki, Tambwe Willy Muzumbukilwa, Mukanda Gedeon Kadima, Ntabaza Ndage, Bakari Salvius Amuri, Kahumba Byanga, Hezekiel M. Kumalo, et al.

    Background Praziquantel is the commonly used conventional treatment recommended for schistosomiasis in the mainstream healthcare system. Although Praziquantel may be free in healthcare facilities, many individuals may resort to the use of traditional medicine. This study aimed to assess perceptions of participants on the availability of Praziquantel and to ascertain whether individuals infected with schistosomiasis used concurrently African traditional medicines with this treatment. Methods A cross–sectional descriptive study, using face-to-face interviews, was conducted from January to April 2023 among healthcare workers (HCWs) and patients. A review of medical chart records of patients was further carried out to triangulate the information from interviews. Ddescriptive statistics including frequency and percentage were used; categorical data were represented as tables. Chi-squared tests were performed for the association between continuous variables. A p value ≤ 0.05 was estimated as statistically significant. Results Most of HCWs (114/124; 91.9%) reported that Praziquantel was available in healthcare facilities. Majority of HCWs (76/124; 61.3%) did not know whether patients seen by them used concurrently traditional medicine and Praziquantel for schistosomiasis. There was no significant relationship between the availability of Praziquantel and the concurrent use of TM by patients for schistosomiasis (X2 = 3.042, p = 0.551). Patients seen by THPs (8/20, 40%) did not use Praziquantel for schistosomiasis. Those patients (8/15, 53.3%) who crossed from TM to the mainstream healthcare system did not disclose their use of TM to HCWs. Their main reason was that concurrent use of TM and Praziquantel could destroy organs or make Praziquantel not to work properly. None of the medical chart records analysed documented the concurrent use of TM and Praziquantel. Conclusion Most of HCWs were not aware of the concurrent use of TM and Praziquantel by patients for the treatment of schistosomiasis. Patients seen by THPs relied solely on TM for schistosomiasis. Although patients indicated crossing from TM to the mainstream healthcare system, there was no evidence of documented use of TM in medical chart records of patients. Further studies are needed to contribute to the knowledge of medicinal plants used by THPs for schistosomiasis.


  • Open Access

    Knowledge, Perceptions, and Experiences of Traditional Health Practitioners about Managing Female Urogenital Schistosomiasis: The Case of ILembe District, KwaZulu-Natal Province, South Africa

    by Aganze Gloire-Aime Mushebenge, Samuel Chima Ugbaja, Nonkululeko Avril Mbatha, Manimani Ghislain Riziki, Tambwe Willy Muzumbukilwa, Mukanda Gedeon Kadima, Ntabaza Ndage, Bakari Salvius Amuri, Kahumba Byanga, Hezekiel M. Kumalo, et al.

    Background: Schistosomiasis is the third most important Neglected Tropical Disease, with more than 4 million South Africans being infected. Cases of re-infection with schistosomiasis after being treated using modern medication has opened ways to seeking alternative treatment modalities using medicinal plants. This study aims to explore and understand the way traditional healers diagnose schistosomiasis, the types of traditional medicines they use to treat it in communities with a high prevalence of infection, and to establish whether the unavailability of prescribed anti-schistosomal medicines leads to the use of traditional medicine. Methods: A qualitative exploratory study was conducted using a questionnaire from December 2022 to March 2023 in the iLembe District, KwaZulu-Natal Province, South Africa. In-depth individual interviews were carried out among traditional health practitioners (THPs) involved in managing female urogenital schistosomiasis (FUS). Recorded narrative data was transcribed verbatim, read through thoroughly and coded, and analysed using thematic or content analysis Results: Traditional Health Practitioners provide services to many women who did not want to be treated in the mainstream health care system for their FUS. The disease was perceived and understood the same way by most of the respondents, that being caused by use of fresh water. Various plants species, either alone or in combination, were used to manage bilharzia in women. Senecio serratuloides (Asteraceae) and Hypoxis hemerocallidea (Hypoxidaceae) were prominently used by THPs in FUS management. Conclusion: Traditional Health Practitioners are playing a key role in managing bilharzia in women in rural areas of the iLembe District, this study reported that THPs can diagnose schistosomiasis symptoms based on their knowledge and experience. Respondents indicated that modern conventional treatment was readily available and free in public sector healthcare facilities; however, they consulted patients suffering from FUS. Various traditional herbal medicines are reportedly used by THPs to manage bilharzia in women. Further studies are needed to investigate the views and experiences of clients regarding the success of the treatments used and why they seek care from THPs.

  • Open Access

    Antibacterial and Antioxidant Activities, Toxicity, and Physicochemical Properties of Crassocephalum montuosum (S Moore) Milne‐Redh and Crassocephalum picridifolium (DC) S Moore

    by Bashige Chiribagula Valentin, Bakari Amuri Salvius, Lumbu Simbi Jean Baptiste

    In traditional Congolese medicine, the plants Crassocephalum montuosum (CrasMon) and Crassocephalum picridifolium (CrasPic) are used to treat bacterial gastroenteritis. In the present study, the antibacterial and antioxidant activities as well as the acute and subacute toxicity of organic extracts from the whole plant of the two investigated taxa were evaluated. Physicochemical parameters were also determined, and total phenolics, flavonoids, and tannins were investigated and assayed. The antibacterial and antioxidant activities of the plant extracts were evaluated using disc diffusion, tube macrodilution, and DPPH tests. Conversely, traditional solution reactions, gravimetric tests, and spectrophotometric tests were used to generate physicochemical profiles, identify secondary metabolite groups, and perform microdilution and DPPH tests to evaluate the antibacterial and antioxidant activities, respectively. OECD tests were adapted to assess the acute and subacute toxicity. All the extracts showed antibacterial activity against E. coli and S. typhi strains with the diameter zone of inhibition (DZI) ranging from 12 to 23 mm and the minimum inhibitory concentration (MIC): 15.625–125 μg·mL−1. The methanolic extract of CrasPic showed the most pronounced activity with a DZI of 21–23 mm and MIC of 15.625–62.5 μg·mL−1. All extracts showed high antioxidant activity with IC50 (half maximal inhibitory concentration) ranging from 11.6 to 21.8 μg·mL−1, with the methanolic extract of CrasMon showing the most pronounced activity. Both plants contain a variety of phytochemicals including coumarins, quinones, flavonoids, phenols, saponins, tannins, and terpenoids. The methanolic extract of CrasPic exhibits the highest content of total phenolics (300 mg·GAE·g−1), flavonoids (56 mg·QE·g−1), and tannins (155 mg·GAE·g−1). These extracts have a median lethal dose (LD50) > 5000 mg·kg−1 and no signs of toxicity at 200 mg·kg−1 after 30 days of oral administration to Cavia porcellus. The total ash content was determined to be 14.2% and 15.8% (on a dry weight basis), with the ash insoluble in hydrochloric acid exhibiting a range of 4.04%–5.03%. CrasMon and CrasPic have been demonstrated to exhibit a good antibacterial and antioxidant activities, at least in part, due to the presence of phenolic compounds. These activities may provide a rationale for their use in traditional Congolese medicine against gastroenteritis.


  • Antimalarial herbal remedies of Bukavu and Uvira areas in DR Congo: An ethnobotanical survey

    by Mboni Henry Manya, Flore Keymeulen, Jérémie Ngezahayo, Amuri Salvius Bakari, Mutombo Emery Kalonda, Byanga Joh Kahumba, Pierre Duez, Caroline Stévigny, Simbi Jean-Baptiste Lumbu